ISDA

Deposition Date 2014-06-19

Release Date 2015-05-06

Last Version Date 2024-02-28

Entry Detail

PDB ID:

4QOC

Keywords:

Ligase/Ligase inhibitor

Title:

crystal structure of compound 16 bound to MDM2(17-111), {(3R,5R,6S)-5-(3-CHLOROPHENYL)-6-(4-CHLOROPHENYL)-1-[(1S)-1-CYCLOPROPYL-2-(PYRROLIDIN-1-YLSULFONYL)ETHYL]-3-METHYL-2-OXOPIPERIDIN-3-YL}ACETIC ACID

Biological Source:

Source Organism:

Homo sapiens (Taxon ID: 9606)

Host Organism:

Escherichia coli

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

1.70 Å

R-Value Free:

0.25

R-Value Work:

0.23

Space Group:

P 21 21 21

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:E3 ubiquitin-protein ligase Mdm2
Gene (Uniprot):MDM2
Chain IDs:A, B (auth: C), C (auth: E), D (auth: G), E (auth: I), F (auth: K)
Chain Length:96
Number of Molecules:6
Biological Source:Homo sapiens

UniProt ID:Q00987 Pfam ID:PF02201 EC:2.3.2.27

Ligand Molecules

35T

Primary Citation

Optimization beyond AMG 232: discovery and SAR of sulfonamides on a piperidinone scaffold as potent inhibitors of the MDM2-p53 protein-protein interaction.

Wang, Y, Zhu, J, Liu, J.J, Chen, X, Mihalic, J, Deignan, J, Yu, M, Sun, D, Kayser, F, McGee, L.R, Lo, M.C, Chen, A, Zhou, J, Ye, Q, Huang, X, Long, A.M, Yakowec, P, Oliner, J.D, Olson, S.H, Medina, J.C.Show

Bioorg.Med.Chem.Lett. 24 3782 3785 (2014)

PMID: 25042256 DOI: 10.1016/j.bmcl.2014.06.073

Abstact

We recently reported on the discovery of AMG 232, a potent and selective piperidinone inhibitor of the MDM2-p53 interaction. AMG 232 is being evaluated in human clinical trials for cancer. Continued exploration of the N-alkyl substituent of this series, in an effort to optimize interactions with the MDM2 glycine-58 shelf region, led to the discovery of sulfonamides such as compounds 31 and 38 that have similar potency, hepatocyte stability and rat pharmacokinetic properties to AMG 232.

Legend

Protein

Chemical

Disease

Primary Citation of related structures